Kim A. Staats

2.7k total citations
26 papers, 848 citations indexed

About

Kim A. Staats is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Kim A. Staats has authored 26 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 8 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Kim A. Staats's work include Amyotrophic Lateral Sclerosis Research (16 papers), Neurogenetic and Muscular Disorders Research (8 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Kim A. Staats is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (16 papers), Neurogenetic and Muscular Disorders Research (8 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Kim A. Staats collaborates with scholars based in Belgium, United States and United Kingdom. Kim A. Staats's co-authors include Ludo Van Den Bosch, Philip Van Damme, Wim Robberecht, Adrian Liston, André Bento‐Abreu, James Dooley, Susann Schönefeldt, Nicole Hersmus, William D. Richardson and Annelies Nonneman and has published in prestigious journals such as Nature Communications, Brain and Development.

In The Last Decade

Kim A. Staats

25 papers receiving 841 citations

Peers

Kim A. Staats

NEURO

GENET

NEURO

PHYSI

Gye Sun Jeon South Korea

Julien Couthouis United States

André Bento‐Abreu Belgium

Annelies Quaegebeur United Kingdom

Se Hee Oh South Korea

Jone López‐Erauskin Spain

Hsueh‐Ning Liu Canada

Nirma D. Perera Australia

Alberto García‐Redondo Spain

Somasish Ghosh Dastidar United States

Gye Sun Jeon South Korea

Kim A. Staats

250 ×0.7

NEURO

506 ×1.4

135 ×0.7

GENET

129 ×1.0

NEURO

145 ×1.1

PHYSI

Citations per year, relative to Kim A. Staats Kim A. Staats (= 1×) peers Gye Sun Jeon

Countries citing papers authored by Kim A. Staats

Since Specialization

Citations

This map shows the geographic impact of Kim A. Staats's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim A. Staats with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim A. Staats more than expected).

Fields of papers citing papers by Kim A. Staats

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim A. Staats. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim A. Staats. The network helps show where Kim A. Staats may publish in the future.

Co-authorship network of co-authors of Kim A. Staats

This figure shows the co-authorship network connecting the top 25 collaborators of Kim A. Staats. A scholar is included among the top collaborators of Kim A. Staats based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim A. Staats. Kim A. Staats is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Staats, Kim A., et al.. (2025). An ALS assembly modulator signature in peripheral blood mononuclear cells: implications for ALS pathophysiology, therapeutics, and diagnostics. Clinical Proteomics. 22(1). 16–16.

Benatar, Michael, Stephen A. Goutman, Kim A. Staats, et al.. (2023). A roadmap to ALS prevention: strategies and priorities. Journal of Neurology Neurosurgery & Psychiatry. 94(5). 399–402. 9 indexed citations

Hendricks, Eric, Jonathan Chang, Kim A. Staats, et al.. (2023). The C9ORF72 repeat expansion alters neurodevelopment. Cell Reports. 42(8). 112983–112983. 4 indexed citations

Staats, Kim A., David Borchelt, Malú G. Tansey, & James Wymer. (2022). Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. Molecular Neurodegeneration. 17(1). 11–11. 49 indexed citations

Shi, Yingxiao, Gabriel S. Rocha, Shao‐Yu Lin, et al.. (2019). Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons. JCI Insight. 4(15). 42 indexed citations

Moore, Stephen, Eric Alsop, Ileana Lorenzini, et al.. (2019). ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD. Acta Neuropathologica. 138(1). 49–65. 51 indexed citations

Staats, Kim A., Timothy Wu, Bing Siang Gan, David B. O’Gorman, & Roel A. Ophoff. (2016). Dupuytren’s disease susceptibility gene, EPDR1, is involved in myofibroblast contractility. Journal of Dermatological Science. 83(2). 131–137. 18 indexed citations

Staats, Kim A., Stéphanie Humblet‐Baron, André Bento‐Abreu, et al.. (2016). Genetic ablation of IP₃receptor 2 increases cytokines and decreases survival ofSOD1^G93Amice. Human Molecular Genetics. 25(16). 3491–3499. 22 indexed citations

Staats, Kim A., Susann Schönefeldt, Lawrence Van Helleputte, et al.. (2015). Transcriptional upregulation of myelin components in spontaneous myelin basic protein-deficient mice. Brain Research. 1606. 125–132. 3 indexed citations

10.

Loohuis, Loes M. Olde, Jacob Vorstman, Anil P. S. Ori, et al.. (2015). Genome-wide burden of deleterious coding variants increased in schizophrenia. Nature Communications. 6(1). 7501–7501. 18 indexed citations

11.

Staats, Kim A., Susann Schönefeldt, Lawrence Van Helleputte, et al.. (2015). C-kit is important for SOD1G93A mouse survival independent of mast cells. Neuroscience. 301. 415–420. 5 indexed citations

12.

Staats, Kim A., Lawrence Van Helleputte, Ashley Jones, et al.. (2013). Genetic ablation of phospholipase C delta 1 increases survival in SOD1G93A mice. Neurobiology of Disease. 60. 11–17. 14 indexed citations

13.

Staats, Kim A., Susann Schönefeldt, André Bento‐Abreu, et al.. (2013). Rapamycin increases survival in ALS mice lacking mature lymphocytes. Molecular Neurodegeneration. 8(1). 31–31. 54 indexed citations

14.

Danso‐Abeam, Dina, Jianguo Zhang, James Dooley, et al.. (2013). Olmsted syndrome: exploration of the immunological phenotype. Orphanet Journal of Rare Diseases. 8(1). 79–79. 39 indexed citations

15.

Philips, Thomas, André Bento‐Abreu, Annelies Nonneman, et al.. (2013). Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain. 136(2). 471–482. 205 indexed citations

16.

Staats, Kim A., Susann Schönefeldt, Annelies Van Hoecke, et al.. (2013). Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis. Frontiers in Cellular Neuroscience. 7. 249–249. 16 indexed citations

17.

Staats, Kim A., Wendy Scheveneels, René Verbesselt, et al.. (2012). Dantrolene is neuroprotective in vitro, but does not affect survival in SOD1G93A mice. Neuroscience. 220. 26–31. 17 indexed citations

18.

Staats, Kim A., Elke Bogaert, Nicole Hersmus, et al.. (2012). Neuronal overexpression of IP3 receptor 2 is detrimental in mutant SOD1 mice. Biochemical and Biophysical Research Communications. 429(3-4). 210–213. 12 indexed citations

19.

Tian, Lei, Gert De Hertogh, Maya Fedeli, et al.. (2012). Loss of T cell microRNA provides systemic protection against autoimmune pathology in mice. Journal of Autoimmunity. 38(1). 39–48. 18 indexed citations

20.

Staats, Kim A. & Ludo Van Den Bosch. (2009). Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival. Journal of Biological Physics. 35(4). 337–346. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact